(Q36682015)

15 August 2017

title

PRO_LIGAND: an approach to de novo molecular design. 4. Application to the design of peptides (English)

1 reference

15 August 2017

0 references

7

1 reference

15 August 2017

Frenkel D

1

1 reference

15 August 2017

Clark DE

2

1 reference

15 August 2017

Li J

3

1 reference

15 August 2017

Murray CW

4

1 reference

15 August 2017

RObson B

5

1 reference

15 August 2017

Waszkowycz B

6

1 reference

15 August 2017

publication date

1 June 1995

1 reference

Journal of Computer - Aided Molecular Design

15 August 2017

published in

1 reference

15 August 2017

volume

9

1 reference

15 August 2017

issue

3

1 reference

15 August 2017

page(s)

213-225

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00124453

15 August 2017

exact match

0 references

cites work

Protein structure--based drug design

1 reference

12 December 2020

Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution

1 reference

12 December 2020

Antibody-antigen complexes

1 reference

12 December 2020

Crystallographic refinement of the three-dimensional structure of the FabD1.3-lysozyme complex at 2.5-A resolution

1 reference

12 December 2020

Tertiary templates for proteins. Use of packing criteria in the enumeration of allowed sequences for different structural classes

1 reference

12 December 2020

A new type of synthetic peptide library for identifying ligand-binding activity

1 reference

12 December 2020

Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries

1 reference

12 December 2020

SPROUT: recent developments in the de novo design of molecules

1 reference

12 December 2020

A unique geometry of the active site of angiotensin-converting enzyme consistent with structure-activity studies

1 reference

12 December 2020

Automated molecular design: a new fragment-joining algorithm.

1 reference

12 December 2020

Automated site-directed drug design using molecular lattices

1 reference

12 December 2020

Computer design of bioactive molecules: a method for receptor-based de novo ligand design

1 reference

12 December 2020

HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site

1 reference

12 December 2020

PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores.

1 reference

12 December 2020

The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure

1 reference

12 December 2020

Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation.

1 reference

12 December 2020

Functionality maps of binding sites: a multiple copy simultaneous search method

1 reference

12 December 2020

Refined models for computer calculations in protein engineering. Calibration and testing of atomic potential functions compatible with more efficient calculations

1 reference

12 December 2020

The computer program LUDI: a new method for the de novo design of enzyme inhibitors

1 reference

12 December 2020

HIV protease (HIV PR) inhibitor structure-activity-selectivity, and active site molecular modeling of high affinity Leu [CH(OH)CH2]Val modified viral and nonviral substrate analogs

1 reference

12 December 2020

NMR structure-based drug design

1 reference

12 December 2020

Application of the three-dimensional structures of protein target molecules in structure-based drug design

1 reference

12 December 2020

Protein targets for structure-based drug design

1 reference

12 December 2020

Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins

1 reference

12 December 2020

On the use of LUDI to search the Fine Chemicals Directory for ligands of proteins of known three-dimensional structure

1 reference

12 December 2020

A novel method for the modelling of peptide ligands to their receptors

1 reference

12 December 2020

Structure-based drug design

1 reference

12 December 2020

Current methods for site-directed structure generation.

1 reference

12 December 2020

The expert system approach to predicting protein structure

1 reference

12 December 2020

PRO-LIGAND: an approach to de novo molecular design. 1. Application to the design of organic molecules

1 reference

12 December 2020

Stereochemistry of polypeptide chain configurations

1 reference

12 December 2020

Structure design: an artificial intelligence-based method for the design of molecules under geometrical constraints.

1 reference

12 December 2020

The ensemble approach to distance geometry: application to the nicotinic pharmacophore

1 reference

12 December 2020

SPROUT: a program for structure generation.

1 reference

12 December 2020

PRO-LIGAND: an approach to de novo molecular design. 3. A genetic algorithm for structure refinement.

1 reference

12 December 2020

LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads

1 reference

12 December 2020

Multiple copy simultaneous search and construction of ligands in binding sites: application to inhibitors of HIV-1 aspartic proteinase

1 reference

12 December 2020

GroupBuild: a fragment-based method for de novo drug design

1 reference

12 December 2020

A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation

1 reference

12 December 2020

Structure-based drug design: progress, results and challenges

1 reference

12 December 2020

Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery

1 reference

12 December 2020

Three-dimensional QSAR of human immunodeficiency virus (I) protease inhibitors. 1. A CoMFA study employing experimentally-determined alignment rules

1 reference

12 December 2020

The use of composite crystal-field environments in molecular recognition and the de novo design of protein ligands

1 reference

12 December 2020

Active human immunodeficiency virus protease is required for viral infectivity

1 reference

12 December 2020

GenStar: a method for de novo drug design.

1 reference

12 December 2020

The NEWLEAD program: a new method for the design of candidate structures from pharmacophoric hypotheses.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00124453

1 reference

journals/jcamd/FrenkelCLMRWW95

15 August 2017

DBLP publication ID

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference